Uflex Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/wj29129zbdcxu9yw4nqjvk7b.pdf

Key Takeaways


Packaging Films: The Correction

Rajesh Bhatia: "I think after a gap of, I would say, close to about three years where there has been only one way up on a quarter-to-quarter basis in terms of the growth charting for the whole packaging films' industry. So this quarter, we've seen a bit of a correction, which is on account of demand slowing down and also some capacity also came on"

Liquid & Flexible Packaging: The Offset

Rajesh Bhatia: "So Asepto margins, I would take it as anywhere between 15% to 17% on a normalized basis. ... normally, our guidance on a medium to long term basis, our guidance on that business is 15% to 17% or 18% kind of a margin depending, so that variation will be more because of the paper or the foil prices."

Capex, Capacity & the Balance Sheet

Rajesh Bhatia: "after we complete the Dharwad, after we see our numbers on the aseptic packaging beginning from coming January. I think that's the time when you would look at, evaluate and then see whether you need to invest more or consolidate for some more time"

Recycling: The First-Mover Bet

Rajesh Bhatia: "it's better to be a pioneer and take a first mover advantage in that field rather than just waiting for it watching the situation and then following others. So we have taken quite an aggressive positioning"

Pricing, Contracts & Raw Material Dynamics

Rajesh Bhatia: "I think this adjustment, which is now happening, will be probably end by the end of this quarter. And then we have a relative stability on the raw material prices as well as substrate prices and all that, and that will be right time to predict the prices for the next one year or so."

Guidance & Commitments

CommitmentSpecificsTimeline
Full-year operating margin~16% (revised from 17–19%), predicated on liquid packaging volumes from January and films margin recoveryFY23
H2 operating profit margin17% combined for H2, not necessarily in Q3H2 FY23
Dharwad BOPET & Dubai CPP commissioningTrial runs underway; commercial production expectedCurrent quarter or early next quarter
Dharwad capacity utilizationReach 80–90%Within 12–18 months
Panipat backward integration (PET chips)Completion, adding security for key raw material and margin supportFY25
Raw material price stabilityAdjustment cycle ends, relative stability beginsEnd of current quarter
Asepto output scale-upFrom 700 crore packs to 900 crore packs from existing plantStarting January
Asepto annual revenue run-rate~₹1,500 crores at 70–80 crore packs per monthFrom January
Recycling facilities (Mexico, Poland, Egypt)All three commissionedWithin FY23
Long-term debt repayment₹500–600 crores per year; FY24 specifically ~₹600 croresAnnual / FY24
Dubai listingInvestment banker targetingQ2–Q3 next financial year (calendar basis)
Value-added products guidanceManagement will provideAfter 1–2 more quarters
Next capacity expansion decisionEvaluate after Dharwad completion and January aseptic numbersPost-January

Key Metrics

MetricQ2 FY23
Revenue growth~27% term-year basis
EBITDA₹493 crores, up 16% YoY
PAT₹190 crores, up 12% YoY
H1 FY23 revenue~₹7,900 crores, up 36%
H1 FY23 EBITDA₹1,218 crores, up 31%
H1 FY23 PAT₹565 crores, up 30%
Liquid packaging revenue growth146% YoY
Flexible packaging revenue growth~28% YoY
Full-year EBITDA margin guidance~16%
H2 operating profit margin guidance17% combined for H2
Aseptic packaging capacity utilizationAbove 90% in lean quarters
Aseptic packaging exports~50% of plant output in lean months
Asepto margins10–11% currently; normalized guidance 15–17% or 18% medium-to-long term
Overall debt increase vs last quarter~₹200 crores
Long-term debt~₹3,700 crores
Short-term debt₹2,068 crores, up from ₹1,491 crores in March
H1 net working capital deployment increase~40%
Hungary energy costs increase (H1 vs same period last year)120%
Poland energy costs increase (H1 vs same period last year)~35%
Dharwad capacity peak revenue potential~₹700 crores top line at ~4,000 tons/month
Panipat backward integration project cost~₹587 crores, expected ROE/ROI ~18%
Long-term debt amortization₹500–600 crores each year
Asepto revenue expectation~₹1,500 crores if doing 70–80 crore packs/month from January